Welcome to the OMA Blog

A new study by Williamson et al. (2025) showed that adding a short sleep screening tool directly into the EHR helped primary care providers identify more sleep disorders and led to more PSG orders and specialty referrals. This is a simple, practical approach that could also be very useful in Obesity Medicine, where sleep screening is still often missed but could make a big impact

The Obesity Medicine Association (OMA) welcomes today’s announcement by the White House Administration regarding expanded access to obesity medications and a commitment to make effective treatment for the chronic disease of obesity more affordable and widely available.

For decades, the number on the scale has been treated as the ultimate benchmark of health. In clinical settings, weight reduction has often been framed as the primary outcome, and weight gain as failure. Yet, as obesity medicine advances, it is increasingly clear that this approach is incomplete and potentially counterproductive. Weight alone fails to capture the complexity of health and behavior change, while overemphasis on the scale can erode trust, reinforce stigma, and undermine long-term engagement (1–3).

A meta-analysis and systematic review of 18 trials including those published in the last 2 years to review primary efficacy outcomes, exploratory efficacy outcomes and safety outcomes. GLP-1 RAs significantly improve outcomes for children and adolescents with Type 2 Diabetes or obesity.

Learn how non-exercise activity thermogenesis (NEAT) supports obesity treatment and explore clinical guidance to boost patient outcomes.

The article warns against relying on lifestyle changes alone when safe, effective GLP-1s exist for pediatric obesity. It urges fair care that blends medical therapy with healthy habits, especially for children facing barriers to lifestyle change.

Explore a complete overview of hyperphagia, including common underlying conditions and emerging studies that all healthcare providers should be aware of.

Childhood obesity rates are climbing worldwide, raising significant public health concerns in an increasingly technology-driven and sedentary world. This trend increases the risk of both short- and long-term health problems, including other serious chronic diseases, mental health challenges, and life-threatening conditions.

It is critical that health care providers can leverage every tool in the obesity care toolbox to develop the best treatment plan for their patients. Sharing this resource – and resources like it - with your patients can help them understand why coverage may have been denied and what steps they can take to access obesity care. Ensure your clinical care team understands approved indications for obesity medicines and can help patients address coverage challenges quickly2 There are many templates and guides available to help your team understand the latest obesity treatment options and tackle common insurance obstacles to help your patients access care. For example: Learn how and why to code for obesity to document treatment effectively and help your patients gain coverage for needed care. By staying informed and raising your voice, and encouraging your patients to do the same, you can help improve coverage for obesity care.